Compare VEEV & IR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | VEEV | IR |
|---|---|---|
| Founded | 2007 | 1859 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Computer Software: Prepackaged Software | Industrial Machinery/Components |
| Sector | Technology | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 39.5B | 32.2B |
| IPO Year | 2013 | N/A |
| Metric | VEEV | IR |
|---|---|---|
| Price | $224.43 | $81.21 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 27 | 7 |
| Target Price | ★ $299.92 | $91.00 |
| AVG Volume (30 Days) | 1.6M | ★ 2.4M |
| Earning Date | 11-20-2025 | 02-12-2026 |
| Dividend Yield | N/A | ★ 0.10% |
| EPS Growth | ★ 26.69 | N/A |
| EPS | ★ 5.13 | 1.35 |
| Revenue | $3,080,246,000.00 | ★ $7,458,300,000.00 |
| Revenue This Year | $17.74 | $8.07 |
| Revenue Next Year | $12.24 | $4.48 |
| P/E Ratio | ★ $43.79 | $60.11 |
| Revenue Growth | ★ 15.96 | 4.20 |
| 52 Week Low | $201.54 | $65.61 |
| 52 Week High | $310.50 | $95.85 |
| Indicator | VEEV | IR |
|---|---|---|
| Relative Strength Index (RSI) | 32.92 | 55.94 |
| Support Level | $221.42 | $78.31 |
| Resistance Level | $225.78 | $84.47 |
| Average True Range (ATR) | 5.47 | 1.79 |
| MACD | 1.74 | 0.07 |
| Stochastic Oscillator | 38.22 | 51.69 |
Veeva is the global leading supplier of cloud-based software solutions for the life sciences industry. The company's best-of-breed offerings address operating and regulatory requirements for customers ranging from small, emerging biotechnology companies to departments of global pharmaceutical manufacturers. The company leverages its domain expertise to improve the efficiency and compliance of the underserved life sciences industry, displacing large, highly customized and dated enterprise resource planning systems that have limited flexibility. Its two main products are Veeva CRM, a customer relationship management platform for companies with a salesforce, and Veeva Vault, a content management platform that tackles various functions within any life sciences company.
Ingersoll Rand was formed through the merger of Gardner Denver and Ingersoll Rand's industrial segment. The firm's portfolio consists of two business lines: industrial technologies and services, and precision and science technologies. Ingersoll Rand serves a variety of end markets, including industrial, medical, and energy. Its broad portfolio of products includes compression, blower and vacuum, and fluid management. Ingersoll Rand generated roughly $7.2 billion in revenue in 2024.